Albany Molecular Research Inc. Files SEC Form PREM14A, Preliminary Proxy Statements Relating To Merger Or Acquisition (Jul. 3, 2017)

Source :: Economics Week. July 21, 2017, 221
Publication Year :: 2017
Abstract: 2017 JUL 21 (VerticalNews) -- By a News Reporter-Staff News Editor at Economics Week -- According to news reporting originating from Washington, D.C., by VerticalNews journalists, a U.S. Securities and [...]

Subjects :: United States. Securities and Exchange Commission
Albany Molecular Research Inc. -- Mergers, acquisitions and divestments
Proxy
Acquisitions and mergers
Company acquisition/merger
Business
Economics

Tools